Is China Medicine Corp. (CHME) a Buy, Sell, or Hold?
OTC : CHME
China Medicine Corp.
$0.02 USD
$0 (0.0%)
- Volume
- 131.5K
- Average Volume
- 4.04K
- Market Capitalization
- $474.24K
- P/E Ratio
- 0.18
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.04
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.10
Company Overview
OTC
Senshan Yang
Medical - Pharmaceuticals
Healthcare
CHME
281
CN
USD
Liquidity Metrics
0.21
2.10
1.91
0.03
0.00
Sales & Valuation
$64.75M
0.01
0.01
0.04
0.87
Profitability
$0.11
$1.72M
2.65%
7.65%
3.91%
2.57%
P/E Metrics
0.18
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
1.81
6/9
$85.75M
$134.04M
$56.12M
$11.7M
Key Metrics (TTM)
$9.51M
0.15
0.72
2.10
3.91%
5.61%
562.53%
2801.50%
$2.73
137 days
Company Executives
| Name | Title |
|---|---|
| Chi Fung | Chief Financial Officer |
| Senshan Yang | Chairman, Chief Executive Officer & Chairman of Guangzhou Konzern Medicine Co., Ltd |
| Huizhen Yu | Controller |
Poll Results
No votes yet today — be the first to share your view!
About China Medicine Corp. (OTC:CHME) Stock
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and ... cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Frequently Asked Questions
-
What is the current China Medicine Corp. (CHME) stock price?
-
China Medicine Corp.(OTC:CHME) stock price is $0.02 in the last trading session. During the trading session, CHME stock reached the peak price of $0.0426 while $0.0005 was the lowest point it dropped to. The percentage change in CHME stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHME stock was $0.
-
CHME's industry and sector of operation?
-
The OTC listed CHME is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of CHME?
-
Chi Fung | Chief Financial Officer
Senshan Yang | Chairman, Chief Executive Officer & Chairman of Guangzhou Konzern Medicine Co., Ltd
Huizhen Yu | Controller
|
| -
How many employees does CHME have?
-
Number of CHME employees currently stands at 281. CHME operates from 2/F, Guangri Tower, Guangzhou, GD 510006, CN.
-
Link for CHME official website?
-
Official Website of CHME is: https://www.cmc621.com
-
How do I contact CHME?
-
CHME could be contacted at phone #86 20 8739 1718 and can also be accessed through its website. CHME operates from 2/F, Guangri Tower, Guangzhou, GD 510006, CN.
-
How many shares of CHME are traded daily?
-
The average number of CHME shares traded daily for last 3 months was 4.04K.
-
What is the market cap of CHME currently?
-
The market value of CHME currently stands at $474.24K with its latest stock price at $0.02